ES2179846T3 - Timo de xenoinjerto. - Google Patents

Timo de xenoinjerto.

Info

Publication number
ES2179846T3
ES2179846T3 ES94917424T ES94917424T ES2179846T3 ES 2179846 T3 ES2179846 T3 ES 2179846T3 ES 94917424 T ES94917424 T ES 94917424T ES 94917424 T ES94917424 T ES 94917424T ES 2179846 T3 ES2179846 T3 ES 2179846T3
Authority
ES
Spain
Prior art keywords
timo
donor
cells
xenoinjerto
injert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94917424T
Other languages
English (en)
Inventor
Megan Sykes
David H Sachs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of ES2179846T3 publication Critical patent/ES2179846T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Glass Compositions (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION DESCRIBE METODOS PARA REEMPLAZAR LA FUNCION DEL TIMO E INDUCIR LA TOLERANCIA INMUNOLOGICA. LOS METODOS INCLUYEN LA INTRODUCCION DE TEJIDO XENOGENETICO DE TIMO Y LA ADMINISTRACION DE CELULAS MADRE DEL DONANTE EN COMBINACION CON REGIMENES TERAPEUTICOS QUE PROMUEVEN LA ACEPTACION DEL INJERTO Y PROLIFERACION DE LAS CELULAS DEL DONANTE.
ES94917424T 1993-05-17 1994-05-16 Timo de xenoinjerto. Expired - Lifetime ES2179846T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6294693A 1993-05-17 1993-05-17
US16391293A 1993-12-07 1993-12-07

Publications (1)

Publication Number Publication Date
ES2179846T3 true ES2179846T3 (es) 2003-02-01

Family

ID=26742900

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94917424T Expired - Lifetime ES2179846T3 (es) 1993-05-17 1994-05-16 Timo de xenoinjerto.

Country Status (10)

Country Link
EP (1) EP0697876B1 (es)
JP (1) JP3553941B2 (es)
AT (1) ATE222111T1 (es)
AU (1) AU694120B2 (es)
CA (1) CA2161797A1 (es)
DE (1) DE69431184T2 (es)
DK (1) DK0697876T3 (es)
ES (1) ES2179846T3 (es)
PT (1) PT697876E (es)
WO (1) WO1994026285A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2524502A (en) * 2000-10-13 2002-04-22 Richard Boyd Improvement of graft acceptance through manipulation of thymic regeneration
BR0114642A (pt) * 2000-10-13 2004-01-20 Univ Monash Prevenção de doenças através da reativação do timo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition

Also Published As

Publication number Publication date
EP0697876B1 (en) 2002-08-14
CA2161797A1 (en) 1994-11-24
DK0697876T3 (da) 2002-09-09
JP3553941B2 (ja) 2004-08-11
ATE222111T1 (de) 2002-08-15
PT697876E (pt) 2002-11-29
EP0697876A4 (en) 1997-09-10
AU6915794A (en) 1994-12-12
WO1994026285A1 (en) 1994-11-24
JPH09500364A (ja) 1997-01-14
EP0697876A1 (en) 1996-02-28
AU694120B2 (en) 1998-07-16
DE69431184D1 (en) 2002-09-19
DE69431184T2 (de) 2003-03-27

Similar Documents

Publication Publication Date Title
ES2170096T3 (es) Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
MX173098B (es) Mejoras en figura posable con piel continua
ES2179077T3 (es) Acido glutamico decarboxilasa clonada.
FI971116L (fi) Fotodynaaminen terapia selektiivisessä solujen inaktivoinnissa veressä sekä immuunijärjestelmän häiriötautien hoito
ES2147752T3 (es) Descontaminacion de plaquetas con 8-metoxipsoraleno.
LV10878A (lv) Adas apstradasana ar izveletiem amfifiliem kopolimeriem
ES2530769T3 (es) Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno
IT8348327A0 (it) Preparato farmaceutico ad azione specifica localizzata e prolungata sul cervello e procedimento di preparazione
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
IT8722408A0 (it) Derivati aromatici biciclici loro procedimento di preparazione e loro impiego in cosmetica e in medicina umana e vetenaria.
AU4786093A (en) Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
ES2057004T3 (es) N-alcoxialquilamidas de hidroxiacidos y composiciones a base de las mismas para el tratamiento de la piel.
TR200001486T2 (tr) Hiperkeratozlu deri hastalıklarının tedavisi için diol ve alfa-hidroksi asitten oluşan bir karışımın kullanılması
ES2039593T3 (es) Cojinetes.
ES2179846T3 (es) Timo de xenoinjerto.
ES2078904T3 (es) Nuevos derivados de neplanocina.
DK93390D0 (da) Ufuldstaendige hepadnavira og cellelinie, der producerer vacciner, samt behandling af leversygdomme og -forstyrrelser
PE3395A1 (es) Articulo absorbente que tiene un parche adhesivo desprendible
MY131599A (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
NO874241D0 (no) Terapeutisk aktive salter.
DE69001776D1 (de) Geformte platteneinheit und mit diesen platteneinheiten versehene quellwasserbehandlungsstruktur.
ES2039516T3 (es) Empleo de los enantiomeros de la propafenona para la obtencion de medicamentos.
MX9701478A (es) Uso de il-4 para aumentar la potencia de agentes quimioterapeuticos.
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais